Department of Rehabilitation, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China.
Medicina (Kaunas). 2022 Jul 20;58(7):958. doi: 10.3390/medicina58070958.
Background and objectives: Coffin-Lowry Syndrome (CLS), a rare neurodegenerative disorder, is mainly diagnosed based on clinical manifestations and molecular analyses. In total, about 20 cases of CLS have been reported in China. Here, we report two cases of CLS in identical twin brothers and examine their potential causative mutations. Methods: The Trio mode was used in this analysis, i.e., DNA from the proband and his parents was sequenced. Furthermore, DNA from the proband’s twin brother was used for confirmation. Results: A hemizygous variation was detected in the 11th exon of the RPS6KA3 gene, c.898C>T (p.R300*) of the proband, and the same site variation was detected in his identical twin brother; however, the mutation was not detected in his parents. Conclusions: The RPS6KA3 gene mutation c.898C>T (p.R300*) is the causative factor of familial CLS. The variant detected was reported for the first time in the Chinese population. Additionally, by analyzing the previous literature, we were able to summarize the phenotypic and genetic characteristics of GLS in China.
Coffin-Lowry 综合征(CLS)是一种罕见的神经退行性疾病,主要基于临床表现和分子分析进行诊断。在中国,约有 20 例 CLS 被报道。在此,我们报告了两例同卵双胞胎兄弟的 CLS 病例,并对其潜在的致病突变进行了检测。方法:采用 Trio 模式对先证者及其父母的 DNA 进行测序。此外,还对先证者的双胞胎兄弟的 DNA 进行了确认。结果:在 RPS6KA3 基因的第 11 外显子中检测到一个杂合变异,c.898C>T(p.R300*),先证者及其同卵双胞胎兄弟均存在该位点的变异,但未在其父母中检测到该突变。结论:RPS6KA3 基因突变 c.898C>T(p.R300*)是家族性 CLS 的致病因素。该变异在中国人群中为首次报道。此外,通过分析以往的文献,我们能够总结中国 CLS 的表型和遗传特征。